Click for best price
RNA In Situ Hybridization Market Size, Share 2023
This report aims to provide a comprehensive presentation of the global market for RNA In Situ Hybridization, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding RNA In Situ Hybridization. This report contains market size and forecasts of RNA In Situ Hybridization in global, including the following market information:
Global RNA In Situ Hybridization Market Revenue, 2018-2023, 2024-2032, ($ millions)
Global top five companies in 2022 (%)
The global RNA In Situ Hybridization market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
GISH Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of RNA In Situ Hybridization include Abbott, Biogenex, Biosb, Roche, Sigma-Aldrich, Advanced Cell Diagnostics, Affymetrix, Exiqon and Agilent Technologies, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the RNA In Situ Hybridization companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global RNA In Situ Hybridization Market, by Type, 2018-2023, 2024-2032 ($ millions)
Global RNA In Situ Hybridization Market Segment Percentages, by Type, 2022 (%)
GISH
FISH
mFISH
PCR
Global RNA In Situ Hybridization Market, by Application, 2018-2023, 2024-2032 ($ millions)
Global RNA In Situ Hybridization Market Segment Percentages, by Application, 2022 (%)
Hospitals
Pharma & Biotech Companies
Research Labs
CROs
Global RNA In Situ Hybridization Market, By Region and Country, 2018-2023, 2024-2032 ($ Millions)
Global RNA In Situ Hybridization Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies RNA In Situ Hybridization revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies RNA In Situ Hybridization revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Abbott
Biogenex
Biosb
Roche
Sigma-Aldrich
Advanced Cell Diagnostics
Affymetrix
Exiqon
Agilent Technologies
Thermo Fisher Scientific
Outline of Major Chapters:
Chapter 1: Introduces the definition of RNA In Situ Hybridization, market overview.
Chapter 2: Global RNA In Situ Hybridization market size in revenue.
Chapter 3: Detailed analysis of RNA In Situ Hybridization company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of RNA In Situ Hybridization in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
RNA In Situ Hybridization Market, Global Outlook and Forecast 2023-2030 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2022 |
| Forecast Year |
2030 |
| Number of Pages |
66 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 RNA In Situ Hybridization Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global RNA In Situ Hybridization Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global RNA In Situ Hybridization Overall Market Size
2.1 Global RNA In Situ Hybridization Market Size: 2022 VS 2030
2.2 Global RNA In Situ Hybridization Market Size, Prospects & Forecasts: 2018-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top RNA In Situ Hybridization Players in Global Market
3.2 Top Global RNA In Situ Hybridization Companies Ranked by Revenue
3.3 Global RNA In Situ Hybridization Revenue by Companies
3.4 Top 3 and Top 5 RNA In Situ Hybridization Companies in Global Market, by Revenue in 2022
3.5 Global Companies RNA In Situ Hybridization Product Type
3.6 Tier 1, Tier 2 and Tier 3 RNA In Situ Hybridization Players in Global Market
3.6.1 List of Global Tier 1 RNA In Situ Hybridization Companies
3.6.2 List of Global Tier 2 and Tier 3 RNA In Situ Hybridization Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global RNA In Situ Hybridization Market Size Markets, 2022 & 2030
4.1.2 GISH
4.1.3 FISH
4.1.4 mFISH
4.1.5 PCR
4.2 By Type - Global RNA In Situ Hybridization Revenue & Forecasts
4.2.1 By Type - Global RNA In Situ Hybridization Revenue, 2018-2023
4.2.2 By Type - Global RNA In Situ Hybridization Revenue, 2024-2030
4.2.3 By Type - Global RNA In Situ Hybridization Revenue Market Share, 2018-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global RNA In Situ Hybridization Market Size, 2022 & 2030
5.1.2 Hospitals
5.1.3 Pharma & Biotech Companies
5.1.4 Research Labs
5.1.5 CROs
5.2 By Application - Global RNA In Situ Hybridization Revenue & Forecasts
5.2.1 By Application - Global RNA In Situ Hybridization Revenue, 2018-2023
5.2.2 By Application - Global RNA In Situ Hybridization Revenue, 2024-2030
5.2.3 By Application - Global RNA In Situ Hybridization Revenue Market Share, 2018-2030
6 Sights by Region
6.1 By Region - Global RNA In Situ Hybridization Market Size, 2022 & 2030
6.2 By Region - Global RNA In Situ Hybridization Revenue & Forecasts
6.2.1 By Region - Global RNA In Situ Hybridization Revenue, 2018-2023
6.2.2 By Region - Global RNA In Situ Hybridization Revenue, 2024-2030
6.2.3 By Region - Global RNA In Situ Hybridization Revenue Market Share, 2018-2030
6.3 North America
6.3.1 By Country - North America RNA In Situ Hybridization Revenue, 2018-2030
6.3.2 US RNA In Situ Hybridization Market Size, 2018-2030
6.3.3 Canada RNA In Situ Hybridization Market Size, 2018-2030
6.3.4 Mexico RNA In Situ Hybridization Market Size, 2018-2030
6.4 Europe
6.4.1 By Country - Europe RNA In Situ Hybridization Revenue, 2018-2030
6.4.2 Germany RNA In Situ Hybridization Market Size, 2018-2030
6.4.3 France RNA In Situ Hybridization Market Size, 2018-2030
6.4.4 U.K. RNA In Situ Hybridization Market Size, 2018-2030
6.4.5 Italy RNA In Situ Hybridization Market Size, 2018-2030
6.4.6 Russia RNA In Situ Hybridization Market Size, 2018-2030
6.4.7 Nordic Countries RNA In Situ Hybridization Market Size, 2018-2030
6.4.8 Benelux RNA In Situ Hybridization Market Size, 2018-2030
6.5 Asia
6.5.1 By Region - Asia RNA In Situ Hybridization Revenue, 2018-2030
6.5.2 China RNA In Situ Hybridization Market Size, 2018-2030
6.5.3 Japan RNA In Situ Hybridization Market Size, 2018-2030
6.5.4 South Korea RNA In Situ Hybridization Market Size, 2018-2030
6.5.5 Southeast Asia RNA In Situ Hybridization Market Size, 2018-2030
6.5.6 India RNA In Situ Hybridization Market Size, 2018-2030
6.6 South America
6.6.1 By Country - South America RNA In Situ Hybridization Revenue, 2018-2030
6.6.2 Brazil RNA In Situ Hybridization Market Size, 2018-2030
6.6.3 Argentina RNA In Situ Hybridization Market Size, 2018-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa RNA In Situ Hybridization Revenue, 2018-2030
6.7.2 Turkey RNA In Situ Hybridization Market Size, 2018-2030
6.7.3 Israel RNA In Situ Hybridization Market Size, 2018-2030
6.7.4 Saudi Arabia RNA In Situ Hybridization Market Size, 2018-2030
6.7.5 UAE RNA In Situ Hybridization Market Size, 2018-2030
7 RNA In Situ Hybridization Companies Profiles
7.1 Abbott
7.1.1 Abbott Company Summary
7.1.2 Abbott Business Overview
7.1.3 Abbott RNA In Situ Hybridization Major Product Offerings
7.1.4 Abbott RNA In Situ Hybridization Revenue in Global Market (2018-2023)
7.1.5 Abbott Key News & Latest Developments
7.2 Biogenex
7.2.1 Biogenex Company Summary
7.2.2 Biogenex Business Overview
7.2.3 Biogenex RNA In Situ Hybridization Major Product Offerings
7.2.4 Biogenex RNA In Situ Hybridization Revenue in Global Market (2018-2023)
7.2.5 Biogenex Key News & Latest Developments
7.3 Biosb
7.3.1 Biosb Company Summary
7.3.2 Biosb Business Overview
7.3.3 Biosb RNA In Situ Hybridization Major Product Offerings
7.3.4 Biosb RNA In Situ Hybridization Revenue in Global Market (2018-2023)
7.3.5 Biosb Key News & Latest Developments
7.4 Roche
7.4.1 Roche Company Summary
7.4.2 Roche Business Overview
7.4.3 Roche RNA In Situ Hybridization Major Product Offerings
7.4.4 Roche RNA In Situ Hybridization Revenue in Global Market (2018-2023)
7.4.5 Roche Key News & Latest Developments
7.5 Sigma-Aldrich
7.5.1 Sigma-Aldrich Company Summary
7.5.2 Sigma-Aldrich Business Overview
7.5.3 Sigma-Aldrich RNA In Situ Hybridization Major Product Offerings
7.5.4 Sigma-Aldrich RNA In Situ Hybridization Revenue in Global Market (2018-2023)
7.5.5 Sigma-Aldrich Key News & Latest Developments
7.6 Advanced Cell Diagnostics
7.6.1 Advanced Cell Diagnostics Company Summary
7.6.2 Advanced Cell Diagnostics Business Overview
7.6.3 Advanced Cell Diagnostics RNA In Situ Hybridization Major Product Offerings
7.6.4 Advanced Cell Diagnostics RNA In Situ Hybridization Revenue in Global Market (2018-2023)
7.6.5 Advanced Cell Diagnostics Key News & Latest Developments
7.7 Affymetrix
7.7.1 Affymetrix Company Summary
7.7.2 Affymetrix Business Overview
7.7.3 Affymetrix RNA In Situ Hybridization Major Product Offerings
7.7.4 Affymetrix RNA In Situ Hybridization Revenue in Global Market (2018-2023)
7.7.5 Affymetrix Key News & Latest Developments
7.8 Exiqon
7.8.1 Exiqon Company Summary
7.8.2 Exiqon Business Overview
7.8.3 Exiqon RNA In Situ Hybridization Major Product Offerings
7.8.4 Exiqon RNA In Situ Hybridization Revenue in Global Market (2018-2023)
7.8.5 Exiqon Key News & Latest Developments
7.9 Agilent Technologies
7.9.1 Agilent Technologies Company Summary
7.9.2 Agilent Technologies Business Overview
7.9.3 Agilent Technologies RNA In Situ Hybridization Major Product Offerings
7.9.4 Agilent Technologies RNA In Situ Hybridization Revenue in Global Market (2018-2023)
7.9.5 Agilent Technologies Key News & Latest Developments
7.10 Thermo Fisher Scientific
7.10.1 Thermo Fisher Scientific Company Summary
7.10.2 Thermo Fisher Scientific Business Overview
7.10.3 Thermo Fisher Scientific RNA In Situ Hybridization Major Product Offerings
7.10.4 Thermo Fisher Scientific RNA In Situ Hybridization Revenue in Global Market (2018-2023)
7.10.5 Thermo Fisher Scientific Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. RNA In Situ Hybridization Market Opportunities & Trends in Global Market
Table 2. RNA In Situ Hybridization Market Drivers in Global Market
Table 3. RNA In Situ Hybridization Market Restraints in Global Market
Table 4. Key Players of RNA In Situ Hybridization in Global Market
Table 5. Top RNA In Situ Hybridization Players in Global Market, Ranking by Revenue (2022)
Table 6. Global RNA In Situ Hybridization Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global RNA In Situ Hybridization Revenue Share by Companies, 2018-2023
Table 8. Global Companies RNA In Situ Hybridization Product Type
Table 9. List of Global Tier 1 RNA In Situ Hybridization Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 RNA In Situ Hybridization Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global RNA In Situ Hybridization Revenue, (US$, Mn), 2022 & 2030
Table 12. By Type - RNA In Situ Hybridization Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - RNA In Situ Hybridization Revenue in Global (US$, Mn), 2024-2030
Table 14. By Application ? Global RNA In Situ Hybridization Revenue, (US$, Mn), 2022 & 2030
Table 15. By Application - RNA In Situ Hybridization Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - RNA In Situ Hybridization Revenue in Global (US$, Mn), 2024-2030
Table 17. By Region ? Global RNA In Situ Hybridization Revenue, (US$, Mn), 2022 & 2030
Table 18. By Region - Global RNA In Situ Hybridization Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global RNA In Situ Hybridization Revenue (US$, Mn), 2024-2030
Table 20. By Country - North America RNA In Situ Hybridization Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America RNA In Situ Hybridization Revenue, (US$, Mn), 2024-2030
Table 22. By Country - Europe RNA In Situ Hybridization Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe RNA In Situ Hybridization Revenue, (US$, Mn), 2024-2030
Table 24. By Region - Asia RNA In Situ Hybridization Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia RNA In Situ Hybridization Revenue, (US$, Mn), 2024-2030
Table 26. By Country - South America RNA In Situ Hybridization Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America RNA In Situ Hybridization Revenue, (US$, Mn), 2024-2030
Table 28. By Country - Middle East & Africa RNA In Situ Hybridization Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa RNA In Situ Hybridization Revenue, (US$, Mn), 2024-2030
Table 30. Abbott Company Summary
Table 31. Abbott RNA In Situ Hybridization Product Offerings
Table 32. Abbott RNA In Situ Hybridization Revenue (US$, Mn) & (2018-2023)
Table 33. Abbott Key News & Latest Developments
Table 34. Biogenex Company Summary
Table 35. Biogenex RNA In Situ Hybridization Product Offerings
Table 36. Biogenex RNA In Situ Hybridization Revenue (US$, Mn) & (2018-2023)
Table 37. Biogenex Key News & Latest Developments
Table 38. Biosb Company Summary
Table 39. Biosb RNA In Situ Hybridization Product Offerings
Table 40. Biosb RNA In Situ Hybridization Revenue (US$, Mn) & (2018-2023)
Table 41. Biosb Key News & Latest Developments
Table 42. Roche Company Summary
Table 43. Roche RNA In Situ Hybridization Product Offerings
Table 44. Roche RNA In Situ Hybridization Revenue (US$, Mn) & (2018-2023)
Table 45. Roche Key News & Latest Developments
Table 46. Sigma-Aldrich Company Summary
Table 47. Sigma-Aldrich RNA In Situ Hybridization Product Offerings
Table 48. Sigma-Aldrich RNA In Situ Hybridization Revenue (US$, Mn) & (2018-2023)
Table 49. Sigma-Aldrich Key News & Latest Developments
Table 50. Advanced Cell Diagnostics Company Summary
Table 51. Advanced Cell Diagnostics RNA In Situ Hybridization Product Offerings
Table 52. Advanced Cell Diagnostics RNA In Situ Hybridization Revenue (US$, Mn) & (2018-2023)
Table 53. Advanced Cell Diagnostics Key News & Latest Developments
Table 54. Affymetrix Company Summary
Table 55. Affymetrix RNA In Situ Hybridization Product Offerings
Table 56. Affymetrix RNA In Situ Hybridization Revenue (US$, Mn) & (2018-2023)
Table 57. Affymetrix Key News & Latest Developments
Table 58. Exiqon Company Summary
Table 59. Exiqon RNA In Situ Hybridization Product Offerings
Table 60. Exiqon RNA In Situ Hybridization Revenue (US$, Mn) & (2018-2023)
Table 61. Exiqon Key News & Latest Developments
Table 62. Agilent Technologies Company Summary
Table 63. Agilent Technologies RNA In Situ Hybridization Product Offerings
Table 64. Agilent Technologies RNA In Situ Hybridization Revenue (US$, Mn) & (2018-2023)
Table 65. Agilent Technologies Key News & Latest Developments
Table 66. Thermo Fisher Scientific Company Summary
Table 67. Thermo Fisher Scientific RNA In Situ Hybridization Product Offerings
Table 68. Thermo Fisher Scientific RNA In Situ Hybridization Revenue (US$, Mn) & (2018-2023)
Table 69. Thermo Fisher Scientific Key News & Latest Developments
List of Figures
Figure 1. RNA In Situ Hybridization Segment by Type in 2022
Figure 2. RNA In Situ Hybridization Segment by Application in 2022
Figure 3. Global RNA In Situ Hybridization Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global RNA In Situ Hybridization Market Size: 2022 VS 2030 (US$, Mn)
Figure 6. Global RNA In Situ Hybridization Revenue, 2018-2030 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by RNA In Situ Hybridization Revenue in 2022
Figure 8. By Type - Global RNA In Situ Hybridization Revenue Market Share, 2018-2030
Figure 9. By Application - Global RNA In Situ Hybridization Revenue Market Share, 2018-2030
Figure 10. By Type - Global RNA In Situ Hybridization Revenue, (US$, Mn), 2022 & 2030
Figure 11. By Type - Global RNA In Situ Hybridization Revenue Market Share, 2018-2030
Figure 12. By Application - Global RNA In Situ Hybridization Revenue, (US$, Mn), 2022 & 2030
Figure 13. By Application - Global RNA In Situ Hybridization Revenue Market Share, 2018-2030
Figure 14. By Region - Global RNA In Situ Hybridization Revenue Market Share, 2018-2030
Figure 15. By Country - North America RNA In Situ Hybridization Revenue Market Share, 2018-2030
Figure 16. US RNA In Situ Hybridization Revenue, (US$, Mn), 2018-2030
Figure 17. Canada RNA In Situ Hybridization Revenue, (US$, Mn), 2018-2030
Figure 18. Mexico RNA In Situ Hybridization Revenue, (US$, Mn), 2018-2030
Figure 19. By Country - Europe RNA In Situ Hybridization Revenue Market Share, 2018-2030
Figure 20. Germany RNA In Situ Hybridization Revenue, (US$, Mn), 2018-2030
Figure 21. France RNA In Situ Hybridization Revenue, (US$, Mn), 2018-2030
Figure 22. U.K. RNA In Situ Hybridization Revenue, (US$, Mn), 2018-2030
Figure 23. Italy RNA In Situ Hybridization Revenue, (US$, Mn), 2018-2030
Figure 24. Russia RNA In Situ Hybridization Revenue, (US$, Mn), 2018-2030
Figure 25. Nordic Countries RNA In Situ Hybridization Revenue, (US$, Mn), 2018-2030
Figure 26. Benelux RNA In Situ Hybridization Revenue, (US$, Mn), 2018-2030
Figure 27. By Region - Asia RNA In Situ Hybridization Revenue Market Share, 2018-2030
Figure 28. China RNA In Situ Hybridization Revenue, (US$, Mn), 2018-2030
Figure 29. Japan RNA In Situ Hybridization Revenue, (US$, Mn), 2018-2030
Figure 30. South Korea RNA In Situ Hybridization Revenue, (US$, Mn), 2018-2030
Figure 31. Southeast Asia RNA In Situ Hybridization Revenue, (US$, Mn), 2018-2030
Figure 32. India RNA In Situ Hybridization Revenue, (US$, Mn), 2018-2030
Figure 33. By Country - South America RNA In Situ Hybridization Revenue Market Share, 2018-2030
Figure 34. Brazil RNA In Situ Hybridization Revenue, (US$, Mn), 2018-2030
Figure 35. Argentina RNA In Situ Hybridization Revenue, (US$, Mn), 2018-2030
Figure 36. By Country - Middle East & Africa RNA In Situ Hybridization Revenue Market Share, 2018-2030
Figure 37. Turkey RNA In Situ Hybridization Revenue, (US$, Mn), 2018-2030
Figure 38. Israel RNA In Situ Hybridization Revenue, (US$, Mn), 2018-2030
Figure 39. Saudi Arabia RNA In Situ Hybridization Revenue, (US$, Mn), 2018-2030
Figure 40. UAE RNA In Situ Hybridization Revenue, (US$, Mn), 2018-2030
Figure 41. Abbott RNA In Situ Hybridization Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Biogenex RNA In Situ Hybridization Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Biosb RNA In Situ Hybridization Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Roche RNA In Situ Hybridization Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Sigma-Aldrich RNA In Situ Hybridization Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Advanced Cell Diagnostics RNA In Situ Hybridization Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Affymetrix RNA In Situ Hybridization Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Exiqon RNA In Situ Hybridization Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Agilent Technologies RNA In Situ Hybridization Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Thermo Fisher Scientific RNA In Situ Hybridization Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
